Download
s12916-020-01719-2.pdf 490,59KB
WeightNameValue
1000 Titel
  • Epidemiological and clinical features of pediatric COVID-19
1000 Autor/in
  1. Guo, Cheng-Xian |
  2. He, Li |
  3. Yin, Ji-Ye |
  4. Meng, Xiang-Guang |
  5. Tan, Wei |
  6. Yang, Guo-Ping |
  7. Bo, Tao |
  8. Liu, Jun-Ping |
  9. Lin, Xin-Jian |
  10. Chen, Xiang |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-08-06
1000 Erschienen in
1000 Quellenangabe
  • 18(1):250
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12916-020-01719-2 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408975/ |
1000 Ergänzendes Material
  • https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-020-01719-2#Sec11 |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • BACKGROUND: COVID-19 is an extremely severe infectious disease. However, few studies have focused on the epidemiological and clinical characteristics of pediatric COVID-19. This study conducted a retrospective review of the epidemiological and clinical features of COVID-19 in children. METHODS: A retrospective study was conducted on children with a definite diagnosis of COVID-19 in mainland China using the web crawler technique to collect anonymous COVID-19 updates published by local health authorities. RESULTS: Three hundred forty-one children aged 4 days to 14 years with a median age of 7 years were included. Sixty-six percent of pediatric patients were infected via family members with COVID-19. The median incubation period was 9 days (interquartile range, 6 to 13). Asymptomatic cases accounted for 5.9%, of which 30% had abnormal chest radiologic findings. A majority of pediatric COVID-19 cases showed mild to moderate clinical features, and only a few developed severe or critical diseases (0.6% and 0.3%, respectively). Fever (77.9%) and cough (32.4%) were the predominant presenting symptoms of pediatric COVID-19. The pediatric patients had fewer underlying diseases and complications than adults. The treatment modalities for pediatric COVID-19 patients were not as complex as those of adult COVID-19 patients. The overall prognosis of pediatric COVID-19 was benign with a decent recovery. The median time from onset to cure was 16 days (interquartile range, 13 to 21). CONCLUSIONS: Compared to adults, COVID-19 in children has distinct features of epidemiology and clinical manifestations. The findings from this study might help to guide the development of measures to prevent and treat this ongoing global pandemic. TRIAL REGISTRATION: Chinese Clinical Trial Registry (chictr.org.cn) identifier: ChiCTR2000030464.
1000 Sacherschließung
lokal Epidemiology
gnd 1206347392 COVID-19
lokal Pediatric
lokal Clinical features
lokal SARS-CoV-2
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/R3VvLCBDaGVuZy1YaWFu|https://frl.publisso.de/adhoc/uri/SGUsIExp|https://frl.publisso.de/adhoc/uri/WWluLCBKaS1ZZQ==|https://frl.publisso.de/adhoc/uri/TWVuZywgWGlhbmctR3Vhbmc=|https://frl.publisso.de/adhoc/uri/VGFuLCBXZWk=|https://frl.publisso.de/adhoc/uri/WWFuZywgR3VvLVBpbmc=|https://frl.publisso.de/adhoc/uri/Qm8sIFRhbw==|https://frl.publisso.de/adhoc/uri/TGl1LCBKdW4tUGluZw==|https://frl.publisso.de/adhoc/uri/TGluLCBYaW4tSmlhbg==|https://frl.publisso.de/adhoc/uri/Q2hlbiwgWGlhbmc=
1000 Label
1000 Förderer
  1. National Natural Science Foundation of China |
  2. National Basic Research Program of China (973 Program) |
  3. Ministry of Health of the People's Republic of China |
  4. Hunan Provincial Science and Technology Department |
  5. Fujian Medical University |
1000 Fördernummer
  1. 81974511; 81530039; 91949207
  2. 2018YFC2000100
  3. 2020ZX09201010
  4. 2019SK2124
  5. XRCZX2017021
1000 Förderprogramm
  1. -
  2. -
  3. National Major New Drug Creation Project of China
  4. Key Research and Development Program of Hunan Province
  5. Startup Fund for High-level Talents
1000 Dateien
  1. Epidemiological and clinical features of pediatric COVID-19
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer National Natural Science Foundation of China |
    1000 Förderprogramm -
    1000 Fördernummer 81974511; 81530039; 91949207
  2. 1000 joinedFunding-child
    1000 Förderer National Basic Research Program of China (973 Program) |
    1000 Förderprogramm -
    1000 Fördernummer 2018YFC2000100
  3. 1000 joinedFunding-child
    1000 Förderer Ministry of Health of the People's Republic of China |
    1000 Förderprogramm National Major New Drug Creation Project of China
    1000 Fördernummer 2020ZX09201010
  4. 1000 joinedFunding-child
    1000 Förderer Hunan Provincial Science and Technology Department |
    1000 Förderprogramm Key Research and Development Program of Hunan Province
    1000 Fördernummer 2019SK2124
  5. 1000 joinedFunding-child
    1000 Förderer Fujian Medical University |
    1000 Förderprogramm Startup Fund for High-level Talents
    1000 Fördernummer XRCZX2017021
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6422534.rdf
1000 Erstellt am 2020-08-13T11:40:09.368+0200
1000 Erstellt von 122
1000 beschreibt frl:6422534
1000 Bearbeitet von 122
1000 Zuletzt bearbeitet 2020-08-13T11:41:31.213+0200
1000 Objekt bearb. Thu Aug 13 11:40:58 CEST 2020
1000 Vgl. frl:6422534
1000 Oai Id
  1. oai:frl.publisso.de:frl:6422534 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source